Cold endoscopic mucosal resection (EMR) demonstrates lower rates of delayed bleeding and perforation but a higher risk for recurrent or residual neoplasia than hot EMR in colorectal polyp treatment.

April 3, 2012 — Adding the targeted agent cetuximab (Erbitux, Bristol-Myers Squibb) to the current standard mFOLFOX6 (5-fluorouracil, leucovorin, and oxaliplatin) chemotherapy regimen in patients with ...

Postoperative circulating tumor DNA (ctDNA)–based minimal residual disease status demonstrated prognostic value for patients with stage 1 to 4 resected colorectal cancer, showing that those with ...

Please provide your email address to receive an email when new articles are posted on . Researchers observed no differences in recurrence after endoscopic local resection of low- or high-risk CRC ...

Polymorphisms of the Repeated Sequences in the Enhancer Region of the Thymidylate Synthase Gene Promoter May Predict Downstaging After Preoperative Chemoradiation in Rectal Cancer PURPOSE: Adjuvant ...

Liver resection is the goal of treatment strategies for liver-confined metastatic colorectal cancer. However, after resection the majority of patients will experience recurrence. Chemotherapy seems to ...

Please provide your email address to receive an email when new articles are posted on . Patients who had detectable ctDNA after resection of stage II colon cancer did not benefit from adjuvant ...

Celebrex improved DFS in ctDNA-positive colon cancer patients, reducing cancer recurrence and death risk by 37% compared to placebo. ctDNA status post-surgery was highly prognostic of DFS and OS, ...

It is critically important that colorectal cancer patients undergo colonoscopy after surgery to ensure that they do not have a second colon cancer, and to find and remove any additional polyps.

Surgery and chemotherapy together improved survival in GIST patients with liver metastases, increasing median cancer-specific ...